Contact
searchSearch
HMP Global

Atopic Dermatitis

NEA Approved Features
Closing Gaps in Eczema Research
06/08/2026
Coleen Stern, MA
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key...
06/08/2026
The Dermatologist
Baldwin
Videos
The Skin Microbiome: Dermatologic Insights
05/22/2026
Hilary E. Baldwin, MD; Riya Gandhi, MA
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how...
05/22/2026
The Dermatologist
NEA Approved Features
Supporting the Transition to Self-Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
Dr Guttman
Conference Coverage
Atopic Dermatitis: OX40, IL-31, Treg Therapy, and the JAK Head-to-Head Era
02/21/2026
Riya Gandhi, MA
A dermatology update on atopic dermatitis therapeutics, highlighting dupilumab, lebrikizumab, nemolizumab, rocatinlimab (OX40), amlitelimab (OX40L), rezpegaldesleukin, and oral JAK inhibitors (upadacitinib, abrocitinib).
A dermatology update on atopic dermatitis therapeutics, highlighting dupilumab, lebrikizumab, nemolizumab, rocatinlimab (OX40), amlitelimab (OX40L), rezpegaldesleukin, and oral JAK inhibitors (upadacitinib, abrocitinib).
A dermatology update on atopic...
02/21/2026
The Dermatologist
Dr Guttman
Conference Coverage
Chronic Hand Eczema: From Pathogenic Subtypes to Targeted JAK and IL-4/13 Therapy
02/20/2026
Riya Gandhi, MA
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic...
02/20/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist
atopic dermatitis
Conference Coverage
Clarifying the Role of IL-13 Inhibitors in Atopic Dermatitis: Clinical Profiles, Comparisons, and Real-World Application
11/26/2025
Jessica Garlewicz
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized...
11/26/2025
The Dermatologist
Linda F. Stein Gold, MD
Conference Coverage
Charting a Path to Higher Treatment Targets With JAK Inhibition in Atopic Dermatitis
11/01/2025
Jessica Garlewicz
The session focused on elevating therapeutic expectations in AD care, analyzing data on existing JAK inhibitors, and encouraging dermatologists to challenge treatment inertia.
The session focused on elevating therapeutic expectations in AD care, analyzing data on existing JAK inhibitors, and encouraging dermatologists to challenge treatment inertia.
The session focused on elevating...
11/01/2025
The Dermatologist
Cover Story
Chronic Hand Eczema: Breaking Out of the Atopic Dermatitis Umbrella
10/06/2025
Jeff Yu, MD
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more...
10/06/2025
The Dermatologist
Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Katrina Abuabara
Videos
Systemic Treatments for Special Populations in Dermatology
09/10/2025
Katrina Abuabara, MD, MA, MSCE
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares...
09/10/2025
The Dermatologist

Multimedia

Baldwin
Videos
The Skin Microbiome: Dermatologic Insights
05/22/2026
Hilary E. Baldwin, MD; Riya Gandhi, MA
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how...
05/22/2026
The Dermatologist
Katrina Abuabara
Videos
Systemic Treatments for Special Populations in Dermatology
09/10/2025
Katrina Abuabara, MD, MA, MSCE
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares...
09/10/2025
The Dermatologist
James Song
Videos
JAK Inhibitors in Treating Atopic Dermatitis
12/02/2024
Eingun James Song, MD, FAAD
In this interview, Dr Song explains the unique mechanisms of JAK inhibitors compared to traditional immunosuppressants in atopic dermatitis treatment.
In this interview, Dr Song explains the unique mechanisms of JAK inhibitors compared to traditional immunosuppressants in atopic dermatitis treatment.
In this interview, Dr Song...
12/02/2024
The Dermatologist
Lawrence F. Eichenfield, MD, FAAD
Videos
Topical Medications in Atopic Dermatitis: Updates and Insights from Latest Guidelines
04/04/2024
Lawrence F. Eichenfield, MD, FAAD
In this interview, Dr Eichenfield outlines key recommendations and updates from the latest guidelines for managing atopic dermatitis with topical medications.
In this interview, Dr Eichenfield outlines key recommendations and updates from the latest guidelines for managing atopic dermatitis with topical medications.
In this interview, Dr...
04/04/2024
The Dermatologist
Dr Jonathan Silverberg
Videos
Insights From Spring AAD 2024: Atopic Dermatitis in Adults
03/19/2024
Jonathan Silverberg, MD
In this feature video, Dr Jonathan Silverberg went over what his session covered prior to Spring AAD 2024.
In this feature video, Dr Jonathan Silverberg went over what his session covered prior to Spring AAD 2024.
In this feature video, Dr...
03/19/2024
The Dermatologist
stein gold
Videos
Non-Steroidal Topical Therapies: Changing Psoriasis and Atopic Dermatitis Treatment
02/20/2024
Linda Stein Gold, MD
In this interview, Dr Linda Stein Gold shares her presentation at the 2023 Fall Clinical Conference on the influence of non-steroidal topical therapies on psoriasis and atopic dermatitis.
In this interview, Dr Linda Stein Gold shares her presentation at the 2023 Fall Clinical Conference on the influence of non-steroidal topical therapies on psoriasis and atopic dermatitis.
In this interview, Dr Linda...
02/20/2024
The Dermatologist
Dr Ilka Netravali
Videos
Initiation of Dupilumab For Severe Atopic Dermatitis and Rapid Resolution of Diffuse Warts
01/15/2024
Arun Netravali, MD, PhD, FAAD
In this feature video, Dr Ilka Netravali shared insights from her study on diffuse warts following initiation of dupilumab for severe atopic dermatitis.
In this feature video, Dr Ilka Netravali shared insights from her study on diffuse warts following initiation of dupilumab for severe atopic dermatitis.
In this feature video, Dr Ilka...
01/15/2024
The Dermatologist
Emma Guttman
Videos
Alopecia Areata: Navigating its Connections with Atopic Dermatitis
01/05/2024
Emma Guttman-Yassky, MD, PhD
In this interview, Dr Guttman-Yassky delves into the intricate landscape of alopecia areata, unraveling its diverse phenotypes, drawing parallels with atopic dermatitis, and providing valuable guidance for clinicians navigating the challenges...
In this interview, Dr Guttman-Yassky delves into the intricate landscape of alopecia areata, unraveling its diverse phenotypes, drawing parallels with atopic dermatitis, and providing valuable guidance for clinicians navigating the challenges...
In this interview, Dr...
01/05/2024
The Dermatologist
Jonathan Silverberg, MD, PhD, MPH
Q&As
Revolutionizing Atopic Dermatitis: Virtual Sessions on Optimizing Patient Care
12/13/2023
Jessica Garlewicz
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
Dr Jonathan Silverberg discussed...
12/13/2023
The Dermatologist
Joslyn Sciacca Kirby
Videos
Insights From Fall Clinical: Using OTC Products
11/15/2023
Joslyn R. Sciacca Kirby, MD
In this feature video, Dr Kirby shares her presentation at the 2023 Fall Clinical Conference on leveraging OTC products in her practice.
In this feature video, Dr Kirby shares her presentation at the 2023 Fall Clinical Conference on leveraging OTC products in her practice.
In this feature video, Dr Kirby...
11/15/2023
The Dermatologist
Goldberg
Videos
Image-Guided SRT for Nonmelanoma Skin Cancer
10/16/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how...
10/16/2026
The Dermatologist
Dr Martina Porter
Videos
Expert Insights: Povorcitinib for Hidradenitis Suppurativa
10/15/2026
Martina Porter, MD; Jessica Garlewicz
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50...
10/15/2026
The Dermatologist
Dr Lisa Swanson
Videos
Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis
10/15/2026
Jessica Garlewicz
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of...
10/15/2026
The Dermatologist
Dr Raj Chovatiya
Videos
Optimizing Biologic Treatment Decisions in Moderate-to-Severe Atopic Dermatitis
10/15/2026
Raj Chovatiya, MD, PhD; Jessica Garlewicz
Raj Chovatiya, MD, PhD, emphasized individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD, emphasized individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD,...
10/15/2026
The Dermatologist
cohen
Videos
Targeting Type 2 Inflammation in Eczema, Prurigo Nodularis, and Urticaria
10/01/2026
Jeffrey M. Cohen, MD; Riya Gandhi, MA
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how...
10/01/2026
The Dermatologist
Goldberg
Videos
Prolactin Receptor Inhibition for Hair Loss: A New Frontier in Hair Regrowth
09/28/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses...
09/28/2026
The Dermatologist
Bloom
Videos
Biostimulatory Fillers in Facial Rejuvenation
09/28/2026
Jason Bloom, MD, FACS; Riya Gandhi, MA
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the...
09/28/2026
The Dermatologist
Doris Day
Videos
Facial Fillers: Holistic Rejuvenation, Facial Balancing, and Natural Results
09/28/2026
Doris Day, MD; Riya Gandhi, MA
Dr Doris Day discusses why facial fillers continue to grow in popularity by shifting beyond simple volumization toward holistic facial balancing and longevity-focused rejuvenation.
Dr Doris Day discusses why facial fillers continue to grow in popularity by shifting beyond simple volumization toward holistic facial balancing and longevity-focused rejuvenation.
Dr Doris Day discusses why...
09/28/2026
The Dermatologist
Helen He
Videos
Inflammaging and Cellular Senescence: Emerging Strategies for Skin Longevity
09/28/2026
Helen He, MD; Riya Gandhi, MA
Dr Helen He discusses how cellular senescence and inflammaging work together to accelerate intrinsic and extrinsic skin aging.
Dr Helen He discusses how cellular senescence and inflammaging work together to accelerate intrinsic and extrinsic skin aging.
Dr Helen He discusses how...
09/28/2026
The Dermatologist
Helen He
Videos
The Science of Skin Aging: Cellular Mechanisms and Targeted Longevity Strategies
09/28/2026
Dr Helen He explores the molecular drivers of skin aging, including cellular senescence, chronic inflammation, oxidative stress, skin barrier dysfunction, and impaired DNA repair.
Dr Helen He explores the molecular drivers of skin aging, including cellular senescence, chronic inflammation, oxidative stress, skin barrier dysfunction, and impaired DNA repair.
Dr Helen He explores the...
09/28/2026
The Dermatologist

From the Issue

NEA Approved Features
Closing Gaps in Eczema Research
06/08/2026
Coleen Stern, MA
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key...
06/08/2026
The Dermatologist
NEA Approved Features
Supporting the Transition to Self-Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist
Cover Story
Chronic Hand Eczema: Breaking Out of the Atopic Dermatitis Umbrella
10/06/2025
Jeff Yu, MD
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more...
10/06/2025
The Dermatologist
NEA Approved Features
Eczema Action Plans: Personalized Tools for Empowering Patients and Enhancing Care
09/08/2025
Jessica Garlewicz
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association...
09/08/2025
The Dermatologist
NEA Approved Features
Eczema in the United States: Insights from a National Study on Prevalence and Co-Occurrence
06/05/2025
Lisa Kuhs, PhD
The All of Us database highlights the complexity of eczema beyond atopic dermatitis and emphasizes the need for a more nuanced approach in both clinical practice and research.
The All of Us database highlights the complexity of eczema beyond atopic dermatitis and emphasizes the need for a more nuanced approach in both clinical practice and research.
The All of Us database...
06/05/2025
The Dermatologist
Cover Story
Advancing Itch Management With Emerging Therapies and Neuromodulation
05/01/2025
Brian Kim, MD, MTR, FAAD
Dr Brian S. Kim unpacks the latest breakthroughs in the neuroimmunology of itch, revealing how innovative targeted treatments are transforming our approach to chronic itch and reshaping dermatologic care.
Dr Brian S. Kim unpacks the latest breakthroughs in the neuroimmunology of itch, revealing how innovative targeted treatments are transforming our approach to chronic itch and reshaping dermatologic care.
Dr Brian S. Kim unpacks the...
05/01/2025
The Dermatologist
Allergen Focus
What’s New in Allergic Contact Dermatitis? 2025’s Allergens on the Rise
05/01/2025
Braily Weber, BS, BA; Sara A. Hylwa, MD
Familiarize yourself with up-and-coming allergens, including their chemical function, role in consumer products, and reported cases of contact allergy.
Familiarize yourself with up-and-coming allergens, including their chemical function, role in consumer products, and reported cases of contact allergy.
Familiarize yourself with...
05/01/2025
The Dermatologist
NEA Approved Features
Addressing Acute Care Needs in Atopic Dermatitis: A Call for Improved Access and Management
03/06/2025
Lisa Kuhs, PhD
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
National Eczema Association...
03/06/2025
The Dermatologist
Clinical Insights
JAK Inhibitors in Atopic Dermatitis Treatment
03/06/2025
Riya Gandhi, MA
“As our understanding of a disease continues to evolve and get more advanced, it lets us develop therapies that are much more targeted in treating the disease,” says Dr Eingun James Song.
“As our understanding of a disease continues to evolve and get more advanced, it lets us develop therapies that are much more targeted in treating the disease,” says Dr Eingun James Song.
“As our understanding of a...
03/06/2025
The Dermatologist
NEA Approved Features
The State of AD: Why We Are Building the First Indicator Report of Its Kind
10/02/2026
Coleen Stern, MA
In this 2-part series, the National Eczema Association outlines its comprehensive State of AD Indicator Report, providing a foundation for targeted action nationwide.
In this 2-part series, the National Eczema Association outlines its comprehensive State of AD Indicator Report, providing a foundation for targeted action nationwide.
In this 2-part series, the...
10/02/2026
The Dermatologist
Cover Story
The Industry Dermatologist: Building a Career at the Intersection of Science, Innovation, and Patient Care
10/02/2026
Ayman Grada, MD, MHA; Riya Gandhi, MA
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his...
10/02/2026
The Dermatologist
Cover Story
Dermatology in the Digital Age: How Technology Is Transforming Clinical Practice
09/03/2026
Daniel M. Siegel, MD, MS, FAAD, FACMS; Riya Gandhi, MA
How can clinicians harness emerging technologies to improve efficiency and patient care while navigating the challenges of privacy, regulation, medicolegal risk, and information overload?
How can clinicians harness emerging technologies to improve efficiency and patient care while navigating the challenges of privacy, regulation, medicolegal risk, and information overload?
How can clinicians harness...
09/03/2026
The Dermatologist
Feature Story
The Eye-Skin Connection: Ocular Red Flags Every Dermatologist Should Know
09/03/2026
Jennifer Cao, MD; Riya Gandhi, MA
From uveitis and ocular cicatricial pemphigoid to SJS/TEN and hydroxychloroquine toxicity, learn what to recognize to help prevent irreversible vision loss through timely referral and multidisciplinary care.
From uveitis and ocular cicatricial pemphigoid to SJS/TEN and hydroxychloroquine toxicity, learn what to recognize to help prevent irreversible vision loss through timely referral and multidisciplinary care.
From uveitis and ocular...
09/03/2026
The Dermatologist
Allergen Focus
Allergic Contact Dermatitis to Benzyl Alcohol
09/03/2026
Hani A. Abi, BA; Sara A. Hylwa, MD; Divya R. Alley, BS; Anne Neeley, MD
This case series highlights clinical patterns of the American Contact Dermatitis Society’s 2026 Allergen of the Year.
This case series highlights clinical patterns of the American Contact Dermatitis Society’s 2026 Allergen of the Year.
This case series highlights...
09/03/2026
The Dermatologist
Feature Story
Special Delivery of Topical Interest: Understanding Vehicle Formulation for Nonsteroidal Prescription Eczema Creams
08/04/2026
Julia Ross, MD; Noah A. Levit, MD, PhD, FAAD
This article examines the evolving landscape of nonsteroidal topical therapies for atopic dermatitis and chronic hand eczema, with a specific focus on how vehicle formulation and excipient selection may influence clinical performance beyond...
This article examines the evolving landscape of nonsteroidal topical therapies for atopic dermatitis and chronic hand eczema, with a specific focus on how vehicle formulation and excipient selection may influence clinical performance beyond...
This article examines the...
08/04/2026
The Dermatologist
Clinical Insights
Improving Quality of Life for Patients With Chronic Spontaneous Urticaria
08/04/2026
Mona Shahriari, MD, FAAD; Riya Gandhi, MA
Advances in our understanding of this complex inflammatory skin disorder are driving more personalized, mechanism-based treatment approaches that can help patients achieve better disease control.
Advances in our understanding of this complex inflammatory skin disorder are driving more personalized, mechanism-based treatment approaches that can help patients achieve better disease control.
Advances in our understanding of...
08/04/2026
The Dermatologist
Allergen Focus
Behind the Bubbles: A Guide to Surfactants as Potential Allergens
08/04/2026
Divya R. Alley, BS; Sara A. Hylwa, MD
This article provides an overview of the common classes of surfactants, including their functionality, routes of exposure, and cases of reported contact allergy.
This article provides an overview of the common classes of surfactants, including their functionality, routes of exposure, and cases of reported contact allergy.
This article provides an...
08/04/2026
The Dermatologist
Cover Story
Ultrasound as a Transformative Tool in Dermatology
08/04/2026
Jane Y. Yoo, MD; Riya Gandhi, MA
Dr Jane Yoo explains how this rapidly expanding technology is helping clinicians uncover hidden disease, improve treatment decisions, and reshape patient care.
Dr Jane Yoo explains how this rapidly expanding technology is helping clinicians uncover hidden disease, improve treatment decisions, and reshape patient care.
Dr Jane Yoo explains how this...
08/04/2026
The Dermatologist
NEA Approved Features
Closing Gaps in Eczema Research
06/08/2026
Coleen Stern, MA
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key...
06/08/2026
The Dermatologist

Quiz

Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Atopic dermatitis
Quiz
The Overlooked Allergen Missing from Most Patch Test Panels
07/25/2025
Riya Gandhi, MA
Think you’re testing for all the right allergens? Take the quiz to learn which emerging culprit in skincare often flies under the radar.
Think you’re testing for all the right allergens? Take the quiz to learn which emerging culprit in skincare often flies under the radar.
Think you’re testing for all the...
07/25/2025
The Dermatologist
Atopic dermatitis
Quiz
Tacrolimus Aggravating Symptoms? Know the Next Best Step
07/18/2025
Riya Gandhi, MA
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.
When dermatitis worsens during...
07/18/2025
The Dermatologist
Atopic dermatitis
Quiz
The Hypoallergenic Paradox: Which Common Additive Can Trigger ACD?
07/11/2025
Riya Gandhi, MA
Test your dermatology knowledge—can you identify the allergen found in hypoallergenic products that’s increasingly associated with allergic contact dermatitis?
Test your dermatology knowledge—can you identify the allergen found in hypoallergenic products that’s increasingly associated with allergic contact dermatitis?
Test your dermatology...
07/11/2025
The Dermatologist
products
Quiz
Hair Product Allergen Exposed: What’s Causing This Dermatitis Pattern?
07/04/2025
Riya Gandhi, MA
A patient presents with scalp and upper back dermatitis after a new conditioner. Can you pinpoint the likely culprit among common hair care allergens?
A patient presents with scalp and upper back dermatitis after a new conditioner. Can you pinpoint the likely culprit among common hair care allergens?
A patient presents with scalp...
07/04/2025
The Dermatologist
Atopic dermatitis
Quiz
Targeting Itch in Atopic Dermatitis: Cytokines and Novel Therapies
05/28/2025
Riya Gandhi, MA
Challenge your dermatology expertise with this interactive quiz on cytokine-driven itch, neuroinflammation, and the latest targeted therapies like dupilumab and nemolizumab.
Challenge your dermatology expertise with this interactive quiz on cytokine-driven itch, neuroinflammation, and the latest targeted therapies like dupilumab and nemolizumab.
Challenge your dermatology...
05/28/2025
The Dermatologist
Atopic dermatitis
Quiz
Manage Acute Flares in Atopic Dermatitis
04/22/2025
Riya Gandhi, MA
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing...
04/22/2025
The Dermatologist
telemedicine
Quiz
Patient-Provider Alignment on AD Flare
03/25/2025
Riya Gandhi, MA
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and...
03/25/2025
The Dermatologist
Atopic Dermatitis + Eczema_2.jpg
Quiz
Key Parts of The Flare Experience
03/16/2025
Riya Gandhi, MA
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the...
03/16/2025
The Dermatologist
Atopic dermatitis
Quiz
Indicators of an AD Flare
03/11/2025
Riya Gandhi, MA
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how...
03/11/2025
The Dermatologist
AD
Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
Quiz
Quiz: Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: When to Escalate to Systemic Therapy
08/10/2026
Riya Gandhi, MA
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment...
08/10/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist

Conference Coverage

Baldwin
Videos
The Skin Microbiome: Dermatologic Insights
05/22/2026
Hilary E. Baldwin, MD; Riya Gandhi, MA
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how...
05/22/2026
The Dermatologist
Dr Guttman
Conference Coverage
Atopic Dermatitis: OX40, IL-31, Treg Therapy, and the JAK Head-to-Head Era
02/21/2026
Riya Gandhi, MA
A dermatology update on atopic dermatitis therapeutics, highlighting dupilumab, lebrikizumab, nemolizumab, rocatinlimab (OX40), amlitelimab (OX40L), rezpegaldesleukin, and oral JAK inhibitors (upadacitinib, abrocitinib).
A dermatology update on atopic dermatitis therapeutics, highlighting dupilumab, lebrikizumab, nemolizumab, rocatinlimab (OX40), amlitelimab (OX40L), rezpegaldesleukin, and oral JAK inhibitors (upadacitinib, abrocitinib).
A dermatology update on atopic...
02/21/2026
The Dermatologist
Dr Guttman
Conference Coverage
Chronic Hand Eczema: From Pathogenic Subtypes to Targeted JAK and IL-4/13 Therapy
02/20/2026
Riya Gandhi, MA
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic...
02/20/2026
The Dermatologist
atopic dermatitis
Conference Coverage
Clarifying the Role of IL-13 Inhibitors in Atopic Dermatitis: Clinical Profiles, Comparisons, and Real-World Application
11/26/2025
Jessica Garlewicz
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized...
11/26/2025
The Dermatologist
Linda F. Stein Gold, MD
Conference Coverage
Charting a Path to Higher Treatment Targets With JAK Inhibition in Atopic Dermatitis
11/01/2025
Jessica Garlewicz
The session focused on elevating therapeutic expectations in AD care, analyzing data on existing JAK inhibitors, and encouraging dermatologists to challenge treatment inertia.
The session focused on elevating therapeutic expectations in AD care, analyzing data on existing JAK inhibitors, and encouraging dermatologists to challenge treatment inertia.
The session focused on elevating...
11/01/2025
The Dermatologist
lisa swanson
Conference Coverage
Breakthroughs in Pediatric Atopic Dermatitis Care
05/16/2025
Riya Gandhi, MA
Lisa Swanson, MD, delivered an engaging overview of evolving treatment strategies for childhood atopic dermatitis—spotlighting new nonsteroidal topicals, simplified routines, and language that resonates with families.
Lisa Swanson, MD, delivered an engaging overview of evolving treatment strategies for childhood atopic dermatitis—spotlighting new nonsteroidal topicals, simplified routines, and language that resonates with families.
Lisa Swanson, MD, delivered an...
05/16/2025
The Dermatologist
Peter Lio
Conference Coverage
Environmental Factors Play a Major Role in Atopic Dermatitis
05/16/2025
Riya Gandhi, MA
Dr Peter Lio explained how pollution, modern lifestyle, and even hygiene products are damaging the skin barrier and fueling the rise in atopic diseases like eczema.
Dr Peter Lio explained how pollution, modern lifestyle, and even hygiene products are damaging the skin barrier and fueling the rise in atopic diseases like eczema.
Dr Peter Lio explained how...
05/16/2025
The Dermatologist
merola
Conference Coverage
The Impact of Topical PDE-4 Inhibitors in Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
05/08/2024
Riya Gandhi, MA
During his session at Spring Dermatology Week 2024, Dr Joseph Merola illuminated the potential of topical phosphodiesterase-4 inhibitors in the management of atopic dermatitis, seborrheic dermatitis, and psoriasis.
During his session at Spring Dermatology Week 2024, Dr Joseph Merola illuminated the potential of topical phosphodiesterase-4 inhibitors in the management of atopic dermatitis, seborrheic dermatitis, and psoriasis.
During his session at Spring...
05/08/2024
The Dermatologist
Goldberg
Videos
Image-Guided SRT for Nonmelanoma Skin Cancer
10/16/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how...
10/16/2026
The Dermatologist
Raj Chovatiya, MD, PhD
Conference Coverage
Individualizing Biologic Therapy for Atopic Dermatitis
10/09/2026
Jessica Garlewicz
Ahead of his session at the 2026 Fall Clinical Dermatology Conference, Raj Chovatiya, MD, PhD, discussed key considerations for individualizing biologic therapy in moderate-to-severe AD.
Ahead of his session at the 2026 Fall Clinical Dermatology Conference, Raj Chovatiya, MD, PhD, discussed key considerations for individualizing biologic therapy in moderate-to-severe AD.
Ahead of his session at the 2026...
10/09/2026
The Dermatologist
Lisa Swanson
Conference Coverage
Expert Insights: Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis
10/09/2026
Jessica Garlewicz
Prior to the 2026 Fall Clinical Dermatology Conference, Lisa Swanson, MD, emphasized that decisions to escalate treatment for moderate-to-severe atopic dermatitis should consider both clinical disease severity and the patient’s experience.
Prior to the 2026 Fall Clinical Dermatology Conference, Lisa Swanson, MD, emphasized that decisions to escalate treatment for moderate-to-severe atopic dermatitis should consider both clinical disease severity and the patient’s experience.
Prior to the 2026 Fall Clinical...
10/09/2026
The Dermatologist
Goldberg
Videos
Prolactin Receptor Inhibition for Hair Loss: A New Frontier in Hair Regrowth
09/28/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses...
09/28/2026
The Dermatologist
Minokadeh
Videos
Injectables for the Male Face: Neuromodulator Dosing and Filler Techniques
06/04/2026
Ardalan Minokadeh, MD, PhD; Riya Gandhi, MA
Dr Ardalan Minokadeh discusses how injectable treatments should be tailored to male facial anatomy, including differences in muscle mass, brow shape, jaw structure, and midface contours.
Dr Ardalan Minokadeh discusses how injectable treatments should be tailored to male facial anatomy, including differences in muscle mass, brow shape, jaw structure, and midface contours.
Dr Ardalan Minokadeh discusses...
06/04/2026
The Dermatologist
thor
Videos
BMI, Biological Aging, and Skin Longevity: Beyond Weight in Dermatology
06/04/2026
Dominik Thor, PhD, MSc; Riya Gandhi, MA
Dominik Thor discusses how obesity, metabolic health, and biological aging intersect to influence skin health and longevity.
Dominik Thor discusses how obesity, metabolic health, and biological aging intersect to influence skin health and longevity.
Dominik Thor discusses how...
06/04/2026
The Dermatologist
ablon
Videos
GLP-1 Dermatologic Side Effects: Facial Volume Loss, Hair Loss, and Skin Changes
06/04/2026
Glynis Ablon; Riya Gandhi, MA
Dr Glynis Ablon discusses the most common dermatologic effects associated with GLP-1 receptor agonists, including facial volume loss, skin laxity, telogen effluvium, hypersensitivity reactions, and delayed wound healing.
Dr Glynis Ablon discusses the most common dermatologic effects associated with GLP-1 receptor agonists, including facial volume loss, skin laxity, telogen effluvium, hypersensitivity reactions, and delayed wound healing.
Dr Glynis Ablon discusses the...
06/04/2026
The Dermatologist
kelly
Videos
Port Wine Capillary Malformations: Laser Treatment and Emerging Options
06/04/2026
Kristen Kelly, MD; Riya Gandhi, MA
Dr Kristen Kelly discusses current and emerging treatment strategies for port wine capillary malformations, including pulsed dye laser, long-pulsed 532 nm lasers, IPL, Alexandrite, and 1064 nm approaches.
Dr Kristen Kelly discusses current and emerging treatment strategies for port wine capillary malformations, including pulsed dye laser, long-pulsed 532 nm lasers, IPL, Alexandrite, and 1064 nm approaches.
Dr Kristen Kelly discusses...
06/04/2026
The Dermatologist
thor
Videos
Longevity Medicine in Dermatology: Prevention, Diagnostics, and Evidence-Based Innovation
06/04/2026
Dominik Thor, PhD, MSc; Riya Gandhi, MA
Dominik Thor discusses how longevity medicine may shape the future of dermatology by shifting care from reactive treatment to preventive, healthspan-focused strategies.
Dominik Thor discusses how longevity medicine may shape the future of dermatology by shifting care from reactive treatment to preventive, healthspan-focused strategies.
Dominik Thor discusses how...
06/04/2026
The Dermatologist
ablon
Videos
Hair Loss Supplements: Evidence-Based Nutraceuticals and Integrative Hair Restoration
06/04/2026
Glynis Ablon; Riya Gandhi, MA
Dr Glynis Ablon discusses how dermatologists can evaluate hair loss supplements using clinical evidence, safety standards, and manufacturing quality rather than marketing claims alone.
Dr Glynis Ablon discusses how dermatologists can evaluate hair loss supplements using clinical evidence, safety standards, and manufacturing quality rather than marketing claims alone.
Dr Glynis Ablon discusses how...
06/04/2026
The Dermatologist

Popular Articles

Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
Riya Gandhi, MA
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies...
11/11/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
Jessica Garlewicz
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
acne
News
Topical Clindamycin: A Safe Choice for Acne Treatment Despite GI Concerns
10/31/2024
Riya Gandhi, MA
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the...
10/31/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Jessica Garlewicz
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
rosacea
News
Consensus on a Core Outcome Set for Rosacea in Clinical Trials and Practice
10/31/2024
Riya Gandhi, MA
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes...
10/31/2024
The Dermatologist
october 2026

Current Issue

October 2026
Volume 34
Issue 7
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Atopic dermatitis
Quiz
The Overlooked Allergen Missing from Most Patch Test Panels
07/25/2025
Riya Gandhi, MA
Think you’re testing for all the right allergens? Take the quiz to learn which emerging culprit in skincare often flies under the radar.
Think you’re testing for all the right allergens? Take the quiz to learn which emerging culprit in skincare often flies under the radar.
Think you’re testing for all the...
07/25/2025
The Dermatologist
Atopic dermatitis
Quiz
Tacrolimus Aggravating Symptoms? Know the Next Best Step
07/18/2025
Riya Gandhi, MA
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.
When dermatitis worsens during...
07/18/2025
The Dermatologist
Atopic dermatitis
Quiz
The Hypoallergenic Paradox: Which Common Additive Can Trigger ACD?
07/11/2025
Riya Gandhi, MA
Test your dermatology knowledge—can you identify the allergen found in hypoallergenic products that’s increasingly associated with allergic contact dermatitis?
Test your dermatology knowledge—can you identify the allergen found in hypoallergenic products that’s increasingly associated with allergic contact dermatitis?
Test your dermatology...
07/11/2025
The Dermatologist
products
Quiz
Hair Product Allergen Exposed: What’s Causing This Dermatitis Pattern?
07/04/2025
Riya Gandhi, MA
A patient presents with scalp and upper back dermatitis after a new conditioner. Can you pinpoint the likely culprit among common hair care allergens?
A patient presents with scalp and upper back dermatitis after a new conditioner. Can you pinpoint the likely culprit among common hair care allergens?
A patient presents with scalp...
07/04/2025
The Dermatologist
Atopic dermatitis
Quiz
Targeting Itch in Atopic Dermatitis: Cytokines and Novel Therapies
05/28/2025
Riya Gandhi, MA
Challenge your dermatology expertise with this interactive quiz on cytokine-driven itch, neuroinflammation, and the latest targeted therapies like dupilumab and nemolizumab.
Challenge your dermatology expertise with this interactive quiz on cytokine-driven itch, neuroinflammation, and the latest targeted therapies like dupilumab and nemolizumab.
Challenge your dermatology...
05/28/2025
The Dermatologist
Atopic dermatitis
Quiz
Manage Acute Flares in Atopic Dermatitis
04/22/2025
Riya Gandhi, MA
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing...
04/22/2025
The Dermatologist
telemedicine
Quiz
Patient-Provider Alignment on AD Flare
03/25/2025
Riya Gandhi, MA
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and...
03/25/2025
The Dermatologist
Atopic Dermatitis + Eczema_2.jpg
Quiz
Key Parts of The Flare Experience
03/16/2025
Riya Gandhi, MA
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the...
03/16/2025
The Dermatologist
Atopic dermatitis
Quiz
Indicators of an AD Flare
03/11/2025
Riya Gandhi, MA
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how...
03/11/2025
The Dermatologist
AD
Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
Quiz
Quiz: Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: When to Escalate to Systemic Therapy
08/10/2026
Riya Gandhi, MA
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment...
08/10/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use